AmyloidosisMultiple MyelomaAmyloidosis, FamilialMyeloma ProteinsBoronic AcidsPyrazinesThalidomideParaproteinemiasPlasma CellsMelphalanAmyloidImmunoglobulin Light ChainsSerum Amyloid A ProteinMonoclonal Gammopathy of Undetermined SignificancePrealbuminDexamethasoneLeukemia, Plasma CellTransplantation, AutologousPlasmacytomaBence Jones ProteinBone MarrowFamilial Mediterranean FeverSyndecan-1beta 2-MicroglobulinAmyloid NeuropathiesParaproteinsImmunoglobulin lambda-ChainsCongo RedAntineoplastic AgentsAmyloid Neuropathies, FamilialCell Line, TumorImmunoglobulin kappa-ChainsHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsBone DiseasesWaldenstrom MacroglobulinemiaProteasome InhibitorsCardiomyopathiesTreatment OutcomeOsteolysisPrognosisChromosomes, Human, Pair 14Interleukin-6Stem Cell TransplantationSerum Amyloid P-ComponentHypergammaglobulinemiaPrednisoneApoptosisFatal OutcomeAntineoplastic Agents, AlkylatingKidney DiseasesTumor Cells, CulturedVincristineMice, SCIDNephrotic SyndromeBone Marrow CellsBiopsyDiphosphonatesRemission InductionTracheal DiseasesSyndecansSurvival RateSurvival AnalysisRecurrenceMaintenance ChemotherapyTranslocation, GeneticDoxorubicinMacroglossiaDisease ProgressionCombined Modality TherapyDrug Resistance, NeoplasmAmyloidogenic ProteinsImmunoglobulin DCyclophosphamideGene Expression Regulation, NeoplasticRetrospective StudiesBone Marrow ExaminationPeripheral Blood Stem Cell TransplantationMyeloablative AgonistsDisease-Free SurvivalAcinonyxProtease InhibitorsStromal CellsChromosomes, Human, Pair 13Cell ProliferationAntibodies, MonoclonalTime FactorsFlow CytometryImmunoglobulinsSalvage TherapyCell SurvivalReceptors, Interleukin-6Hematopoietic Stem Cell MobilizationGelsolinPeripheral Nervous System DiseasesTransplantation ConditioningChromosomes, Human, Pair 4Follow-Up StudiesImmunologic FactorsReceptor, Fibroblast Growth Factor, Type 3